Investment in pharmaceutical industry sector in Dhofar stands at OMR90 million
Salalah: Dhofar Governorate boasts remarkable development in the field of localizing pharmaceutical industries and medical supplies. The drive is aimed to secure the availability of medical drugs in the Sultanate of Oman and meet the needs of the local and regional markets. Investments to this effect stand at RO 90 million.
Ibrahim Nasser Al Rashdi, Director General of the Drug Safety Centre at the Ministry of Health, told Oman News Agency (ONA) that pharmaceutical industry in Dhofar Governorate is burgeoning through three major pharmaceutical factories that help contribute to the needs of the health sector and diminish dependence on imports.
Al Rashdi said that Dhofar pharmaceutical industries unit in Raysut Industrial City, inaugurated in September 2024, was set up at a total cost of more than RO 15 million. The unit, he explained, is one of the pharmaceutical projects specialized in producing intravenous solutions and dialysis solutions using advanced technologies in accordance with the highest international quality standards.
He added that the unit in Raysut Industrial City, built on an area of 22,000 square metres, meets the needs of the local market for pharmaceutical solutions, which contributes to achieving drug security in the Sultanate of Oman, the Middle East and North Africa.
The factory has an annual production volume of 15 million units of intravenous solution, along with 2.3 million units of kidney dialysis solutions, said Al Rashdi, noting that the factory meets the demand of the Omani health sector, thanks to its output estimated at 5 million units a year.
Speaking about another unit, Oman Pharmaceutical Industries Company factory, Al Rashdi said that the company has been one of the most prominent pharmaceutical manufacturers in the Sultanate of Oman since its establishment in 2001.
The factory has a cumulative investment volume of RO 35 million. Based in Raysut Industrial City in Salalah, the company aims to enhance the local pharmaceutical industry and provide high-quality pharmaceutical products to the Omani and global markets, Al Rashdi added.
He added that Oman Pharmaceutical Industries Company's factory produces a wide range of medicines, including antibiotics, hormones, topical preparations, effervescent tablets and solid and liquid pharmaceutical forms.
The unit's products are exported to more than 45 countries around the world, including the United States and Europe, which affirms its commitment to international quality standards, he explained.
Al Rashidi pointed out that Raysut Industrial City includes a factory specialized in the production of medical supplies like gloves, medical masks and respirators.
The unit has an investment value of approximately RO 5 million, said Al Rashdi, noting that the unit is capable of meeting the needs of the local and GCC health sectors.
Al Rashdi said that Salalah Medical Supplies Manufacturing Company was established in 1997 and that the company's factory is also located in Raysut Industrial City on an area of 18,000 square metres. He added that the factory's products include supplying a wide range of medical gloves, masks, cotton, bandages and adhesive tapes.
The unit provides and distributes its products within the Sultanate of Oman and exports them to other GCC states.
Speaking about pharmaceutical industry in Salalah Free Zone, Al Rashdi said that investment in the Felix Pharmaceutical Industries factory is estimated at RO 35 million.
The objective is to transform the Salalah Free Zone into a regional hub for pharmaceutical and biological industries, thus contributing to achieving drug security in the Sultanate of Oman and GCC states.
Al Rashdi added that the factory seeks to produce more than 100 pharmaceutical products, including antivirals, as well as heart disease medications and vaccines in later stages. The production capacity of the first phase is expected to reach one billion tablets and one billion capsules a year, he explained.
It's worth noting that the Sultanate of Oman seeks to enhance drug security by encouraging national and international investments in the medical industry. This aims to diminish dependence on drug imports and increase production to meet local needs in line with the goals of Oman Vision 2040.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Times of Oman
6 hours ago
- Times of Oman
Piyush Goyal defends India's IP record, slams push for 'evergreening' patents
Bern: Indian Union Commerce and Industry Minister Piyush Goyal defended India's intellectual property practices during a press conference with Swiss journalists on Tuesday, challenging pharmaceutical companies to provide evidence of patent violations while criticizing the practice of "evergreening" patents that he said deprives people of affordable healthcare. Goyal met representatives from Swiss pharmaceutical industry. "I asked them a simple question, show me one instance where we have illegally copied any of your trademarks or any patent or any of your copyright technology," Goyal told reporters. "I was shown none, not one. This is a myth which has been propagated for years," he said. The minister emphasised India's commitment to respecting intellectual property rights, contrasting the country's approach with what he described as the poor track record of some other nations. "India is very respectful of intellectual property rights. India is very conscious of its responsibilities, and India is a country known to never, ever steal anybody else's technology," he said. Goyal drew a clear distinction between respecting valid patents and opposing what he termed "evergreening" - the practice of making minor modifications to extend patent life beyond the original term. He argued that India's position on this issue serves broader humanitarian interests. "The only thing that India does not permit is evergreening of patents," he explained. "During the patent life, there is not a single instance of misuse, but after the patent runs out its tenure, there are unfortunately a few companies or players who make very minor modifications and try to get another extended patent life." The Commerce Minister argued that such practices harm consumers globally, not just in developing countries. "This is depriving even the Swiss people of affordable healthcare. When you do such evergreening, other than benefiting a few handful large companies, you are causing a loss to billions of citizens, not only in Switzerland, but across the world," he added. Goyal positioned India's approach as protecting the rights of both innovators and consumers, arguing that companies should be able to recover their research and development investments during the original patent period without indefinitely extending monopolies. "We in India believe that our people, as they aspire for a better quality of life, as we grow our economy, deserve quality healthcare at affordable prices, as I believe the Swiss people do," he stated. Goyal reported positive engagement with Swiss pharmaceutical companies during the discussions. He credited industry representatives with providing constructive suggestions that have been implemented in India. "I must thank the pharma companies of Switzerland for their deep understanding and support to this agreement," the minister said. "They gave me a lot of wonderful suggestions, which I have implemented in India. I've earned their trust." Goyal expressed confidence about expanding partnerships between Indian and international pharmaceutical companies. He emphasized the mutual benefits of collaboration, particularly India's large domestic market and potential for global expansion. "I am confident that in the years ahead, the pharma companies of Switzerland or the EFTA countries or other European and American pharmaceutical companies will work with India as partners and enjoy the fruits of this large 1.4 billion market in India," he said. The minister highlighted how affordable pricing strategies could benefit international pharmaceutical companies by opening new markets while serving humanitarian goals. "With affordable products, they'll be able to capture global markets, not only for better profits, but also as a service to humanity," the minister said. Goyal held high-level meetings with Swiss government officials and business leaders to strengthen bilateral trade and investment relationships. The pharmaceutical sector discussions represent a significant component of broader economic cooperation talks between the two countries. The minister's robust defence of India's intellectual property framework appears to have addressed Swiss industry concerns while establishing clear parameters for future collaboration in the pharmaceutical sector.
Times of Oman
14 hours ago
- Times of Oman
IMF expert mission commends CBO's transparency practices
Muscat-- The International Monetary Fund (IMF) has issued and published a report on the transparency of the Central Bank of Oman (CBO) based on the IMF's best practices for central bank transparency (CBT). The report issued today said that this voluntary assessment was conducted to review the transparency and disclosure practices of CBO, focusing on five key areas, as issued by the IMF: governance; transparency of policies, operations, outcomes and official relations of central banks. This assessment serves to enhance CBO's independence and its relations with relevant stakeholders and facilitates information sharing and intellectual exchange with counterparts. The IMF report concluded that CBO places great importance on transparency in its practices, in line with international best practices. This reflects its commitment to strengthening its role as a critical public institution in the country through a robust transparency framework. The Sultanate of Oman is the first country among the Gulf Cooperation Council (GCC) States to undergo this voluntary assessment and the second among Arab countries. This reflects CBO's commitment to advancing to the highest international standards and practices. During its field visit, the IMF held extensive meetings with stakeholders from CBO and relevant government, private, and civil society organizations to assess its transparency practices and governance frameworks. This ensures constructive dialogue with stakeholders to achieve more effective outcomes in monetary and banking policies. The report's most prominent findings indicate strong governance and a sound legal framework. The CBO has a strong legal framework for internal governance, with a clear legal structure and broad powers, which enhances decision-making and accountability. The report also highlights the monetary policy transparency as the CBO ensures transparency in monetary policy and the stability of the financial system through cooperation with other financial institutions in the country, as well as through the issuance of regular bulletins and periodicals to ensure effective communication. Additionally, the report spotlights effective financial stability tools as IMF experts found that CBO is focusing on enhancing tools related to the Emergency Liquidity Response (ELA) and macro-financial stability, reflecting its ongoing efforts to improve the transparency of financial system stability management in the Sultanate of Oman. Further, the report underlines commitment to stakeholder communication as the CBO is working to enhance its communication with the public, ensuring that key policy decisions are accessible and understandable, including through its website and social media channels. In addition, the CBO's efforts to strengthen its AML/CFT framework were commended, and the review encouraged it to continue enhancing transparency in its supervisory and oversight practices in this area. It is noteworthy that the IMF issued the "Central Bank Transparency Code" in 2020, reflecting the growing responsibilities and significant expansion in the requirement for central banks to clarify the nature, purpose, and manner of their activities. This allows for a deeper public understanding of the role of these activities in optimally serving their interests, consistent with current mandates, enhancing central bank independence, and enhancing the impact of monetary and banking policies. Accordingly, the CBO has taken into account the recommendations presented by the IMF team and is committed to continuing to enhance transparency in line with the objectives of Oman Vision 2040 and international best practices, while considering the local context and national legal framework. The mission provided an opportunity for self-assessment, in conjunction with the CBO's ongoing efforts to modernize its legal and regulatory frameworks. The CBO will develop a plan to implement the recommendations and findings contained in the IMF report, which will contribute to ongoing improvements in the transparency of its operations, practices, and policies to ensure sustainable economic growth.
Times of Oman
18 hours ago
- Times of Oman
Pact signed for health-promoting educational environment in Oman schools
Muscat: The Ministry of Education, Ministry of and Health, and Al Jisr Charitable Foundation signed a cooperation agreement to support the health promoting schools initiative at Al Jisr Charitable Foundation's headquarters in Muscat. The agreement aims to provide a safe and health-promoting educational environment for schools, enabling students to enhance their academic achievement, acquire necessary life skills, and integrate into society. The agreement was signed on behalf of the Ministry of Education by Dr. Abdullah bin Khamis Ambosaidi, Undersecretary for Education; on behalf of the Ministry of Health by Sulaiman bin Nasser Al-Hajji, Undersecretary for Administrative and Financial Affairs; and on behalf of the Al Jisr Charitable Foundation by Dina Al Khalili, Director-General of the Foundation. On the importance of signing the agreement to support the health promoting schools initiative, Dr. Abdullah bin Khamis Ambosaidi, said: 'This initiative, which will be implemented over the next five years, is of great importance in promoting a healthy environment for students, as it is a key tool that positively reflects on their academic achievement. 'The total number of schools participating in this initiative since its launch has reached 566 from various educational directorates in the governorates, in which the various initiative programmes are implemented in cooperation with the Ministry of Health and Al Jisr Charitable Foundation.' Sulaiman bin Nasser Al Hajji, Undersecretary of the Ministry of Health for Administrative and Financial Affairs, stated: 'This initiative stems from a strategic partnership to achieve the common good of society and promote health in the school environment, in particular, by improving the learning environment for students, enhancing their academic achievement, protecting them from diseases, reducing their absence from school, enhancing their mental health, and building lasting healthy habits for these students, so that they are more able to focus, pay attention, and learn.' Regarding the community partnership between Al Jisr Charitable Foundation and the government sector, Dina Al Khalili, the Foundation's Director-General, said: 'This strategic partnership embodies the convergence of healthcare and educational efforts and achieves our shared vision of providing a healthy school environment that enhances students' academic achievement and develops their necessary life skills. 'We appreciate the role of the Ministries of Education and Health for their trust and cooperation in this initiative, and we affirm our commitment to achieving a sustainable impact for students and society.' It's worth noting that Al Jisr Foundation is funding sustainable projects for three schools that have achieved the highest gold rating in the health promoting schools initiative over a five-year period. It also provides general oversight of the initiative's implementation and collaborates with a specialised team from both ministries to develop a visual identity and guidelines for the initiative. It is also working on developing an electronic platform for the initiative, which will be launched at a later time.
